ADx-001

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameADx-001
Drug Alias NameADx (University of Houston)DSPE-DOTA-Gd liposomal injectionADx (Alzeca Biosciences)
ClassificationOther
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Houston
China Registration ClassN/A

Develop Information

Active CompaniesAlzeca Biosciences Inc
Inactive CompaniesUniversity Of Houston
Active IndicationsAlzheimer DiseaseDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A